NanoString Technologies, Inc. (NASDAQ:NSTG) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.45) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.56) by $0.11, reports. The company had revenue of $27.02 million for the quarter, compared to analysts’ expectations of $26.27 million. NanoString Technologies had a negative net margin of 44.24% and a negative return on equity of 227.21%. NanoString Technologies’s revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.51) EPS. NanoString Technologies updated its FY17 guidance to ($1.99-1.86) EPS.

Shares of NanoString Technologies (NSTG) traded down $2.12 during midday trading on Friday, hitting $7.79. 1,240,311 shares of the company’s stock traded hands, compared to its average volume of 359,709.

Several equities analysts have issued reports on the stock. Zacks Investment Research raised shares of NanoString Technologies from a “hold” rating to a “buy” rating and set a $17.00 price objective on the stock in a research note on Thursday, August 10th. Cowen and Company cut shares of NanoString Technologies from an “outperform” rating to a “market perform” rating in a research note on Thursday, October 12th. BidaskClub cut shares of NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Robert W. Baird dropped their price objective on shares of NanoString Technologies from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday. Finally, ValuEngine cut shares of NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, July 13th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $17.25.

ILLEGAL ACTIVITY WARNING: This story was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Earnings History for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with's FREE daily email newsletter.